Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL - Part 1: results of a retrospective evaluation of 1726 men

By Tornblom M.   Norming U.   Adolfsson J.   Becker C.   Abrahamsson P.-A.   Lilja H.   Gustafsson O.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 945-950

Elsevier

Access to resources Recommend Favorite

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density

By Bangma C.H.   Kranse R.   Blijenberg B.G.   Schroder F.H.  

Urology, Vol. 46, Iss. 6, 1995-12 ,pp. : 779-784

Elsevier

Access to resources Recommend Favorite

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer:results of a large screening study

By Reissigl A.   Pointner J.   Horninger W.   Ennemoser O.   Strasser H.   Klocker H.   Bartsch G.  

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 662-665

Elsevier

Access to resources Recommend Favorite

Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations

By Ito K.   Kubota Y.   Suzuki K.   Shimizu N.   Fukabori Y.   Kurokawa K.   Imai K.   Yamanaka H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 705-709

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? part I: framing the debate

By Barry M.J.   Fleming C.   Coley C.M.   Wasson J.H.   Fahs M.C.   Oesterling J.E.  

Urology, Vol. 46, Iss. 1, 1995-07 ,pp. : 2-13

Elsevier

Access to resources Recommend Favorite